Meeting
2019 Genitourinary Cancers Symposium
Proposal for tripartite re-classification of T1 renal cell carcinoma into cT1a (very low risk), cT1b (low risk), and cT1c (intermediate risk) substages.
Authors
Aaron Bradshaw
University of California San Diego, San Diego, CA
Aaron Bradshaw , Robert Uzzo , Alessandro Larcher , Ahmed Eldefrawy , Umberto Capitanio , Shreyas Joshi , Stephen Ryan , Margaret Frances Meagher , Brittney Cotta , Addison Yee , Fang Wan , Francesco Montorsi , Ithaar Derweesh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 618)
DOI
10.1200/JCO.2019.37.7_suppl.618
Abstract #
618
Poster Bd #
G13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Does presence of diabetes mellitus impact patient oncological outcomes in renal cell carcinoma: A multicenter analysis.
First Author: Ava Saidian
Poster
2020 Genitourinary Cancers Symposium
Impact of diabetes mellitus on functional and survival outcomes in renal cell carcinoma: An international multicenter study.
First Author: Raksha Dutt
Poster
2023 ASCO Annual Meeting
Impact of risk factors on overall survival (OS) in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with first-line (1L) tislelizumab (TIS).
First Author: Masatoshi Kudo
Poster
2023 ASCO Genitourinary Cancers Symposium
A comparison of radiographic and morphometric characteristics and outcomes in T3a pathologically upstaged and non-upstaged renal cell carcinoma.
First Author: Saeed Ghassemzadeh